Literature DB >> 8916036

Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.

G D Moore1, T Ayabe, G S Kopf, R M Schultz.   

Abstract

Cell-cycle progression in somatic cells is regulated by a family of cyclins and cyclindependent kinases (cdks) that form specific complexes as a function of cell-cycle progression. However, the transcript abundance of G1-S cyclins and cdks during the meiotic and mitotic cell cycles of mammalian embryos has not been previously reported. Using a reverse transcription-polymerase chain reaction (PCR) assay that detects changes in either mRNA abundance or polyadenylation state, we examined the relative levels of gene expression for the G1-S cyclins and cdks, as well as for p21, p27, and the retinoblastoma (Rb) gene in mouse oocytes, metaphase II-arrested eggs, and 1-2-cell embryos. The PCR products for cyclins D1, D3, and A, as well as cdk4, p21, and Rb, displayed similar levels in meiotically incompetent and competent oocytes, as well as in metaphase II-arrested eggs. The levels of PCR products for cyclin D2, p27, and two forms of cdk2 were similar in meiotically incompetent and competent oocytes but decreased during oocyte maturation. Finally, the level of PCR products for cyclin E and cdk2 gradually decreased during the progression from meiotically incompetent oocytes to metaphase II-arrested eggs. When the levels of PCR products for the G1-S regulatory genes were evaluated during the first and second mitotic cell cycles, four main patterns were found: 1) steady levels for cyclin A; 2) steady levels followed by a 2-3-fold increase during the G2 phase of the second mitotic cell cycle for cyclins D1, E, cdk2, and p21; 3) a transient increase during the S and/or G2 phases of the first mitotic cell cycle for p27, cyclin D3, and the two forms of cdk2; and 4) higher levels during the first cell cycle and then a decrease with lower levels during the second mitotic cell cycle for cyclin D2 and Rb. cdk4 expression displayed a combination of patterns 2 and 3. The increase in the amount of PCR product for the cdk4 gene during the first mitotic cell cycle was due to polyadenylation, whereas the increase in the amount of PCR product for cdk4, cdk2, and cyclins D1 and E in the second mitotic cell cycle was a product of activation of the embryonic genome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916036     DOI: 10.1002/(SICI)1098-2795(199611)45:3<264::AID-MRD2>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  10 in total

1.  The CRY box: a second APCcdh1-dependent degron in mammalian cdc20.

Authors:  Alexandra Reis; Mark Levasseur; Heng-Yu Chang; David J Elliott; Keith T Jones
Journal:  EMBO Rep       Date:  2006-07-28       Impact factor: 8.807

2.  Sperm-borne microRNA-34c is required for the first cleavage division in mouse.

Authors:  Wei-Min Liu; Ronald T K Pang; Philip C N Chiu; Benancy P C Wong; Kaiqin Lao; Kai-Fai Lee; William S B Yeung
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

3.  Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia.

Authors:  Aric W Ledford; Jennifer G Brantley; Gabor Kemeny; Tonia L Foreman; Susan E Quaggin; Peter Igarashi; Stephanie M Oberhaus; Marianna Rodova; James P Calvet; Gregory B Vanden Heuvel
Journal:  Dev Biol       Date:  2002-05-01       Impact factor: 3.582

4.  Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model.

Authors:  Shikha Tarang; Songila M S R Doi; Channabasavaiah B Gurumurthy; Donald Harms; Rolen Quadros; Sonia M Rocha-Sanchez
Journal:  Front Cell Neurosci       Date:  2015-02-23       Impact factor: 5.505

5.  Disruption of the Aldehyde Dehydrogenase 2 Gene Results in No Increase in Trabecular Bone Mass Due to Skeletal Loading in Association with Impaired Cell Cycle Regulation Through p21 Expression in the Bone Marrow Cells of Mice.

Authors:  Kayoko Furukawa Okuma; Kunitaka Menuki; Manabu Tsukamoto; Takafumi Tajima; Hokuto Fukuda; Yasuaki Okada; Toshiharu Mori; Takuto Tsuchiya; Toshihiro Kawamoto; Yasuhiro Yoshida; Soshi Uchida; Akinori Sakai
Journal:  Calcif Tissue Int       Date:  2017-05-04       Impact factor: 4.333

6.  Culture time of vitrified/warmed zygotes before microinjection affects the production efficiency of CRISPR-Cas9-mediated knock-in mice.

Authors:  Yoshiko Nakagawa; Tetsushi Sakuma; Norihisa Nishimichi; Yasuyuki Yokosaki; Toru Takeo; Naomi Nakagata; Takashi Yamamoto
Journal:  Biol Open       Date:  2017-05-15       Impact factor: 2.422

7.  Coping with DNA Double-Strand Breaks via ATM Signaling Pathway in Bovine Oocytes.

Authors:  Lili Wang; Xiaolei Xu; Mingming Teng; Guimin Zhao; Anmin Lei
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

8.  Meiosis Resumption of Immature Human Oocytes following Treatment with Calcium Ionophore In Vitro.

Authors:  Elham Fazeli; Ahmad Hosseini; Mohammad-Hasan Heidari; Fattaneh Farifteh-Nobijari; Mohammad Salehi; Hojjat-Allah Abbaszadeh; Hamid Nazarian; Zahra Shams Mofarahe; Saman Ayoubi; Sara Hosseini; Mona Shayeghpour; Mojgan Bandehpour; Marefat Ghaffari Novin
Journal:  Cell J       Date:  2021-03-01       Impact factor: 2.479

9.  Chromatin dynamics through mouse preimplantation development revealed by single molecule localisation microscopy.

Authors:  Marta Portela; Daniel Jimenez-Carretero; Veronica Labrador; Maria Jose Andreu; Elvira Arza; Valeria R Caiolfa; Miguel Manzanares
Journal:  Biol Open       Date:  2022-07-29       Impact factor: 2.643

10.  Zygotic G2/M cell cycle arrest induced by ATM/Chk1 activation and DNA repair in mouse embryos fertilized with hydrogen peroxide-treated epididymal mouse sperm.

Authors:  Bin Wang; Zhiling Li; Chao Wang; Man Chen; Jianfeng Xiao; Xiaoyan Wu; Wanfen Xiao; Yu Song; Xiaoyan Wang
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.